Trade Summary
1 month ago, New Enterprise Associates 17, L.P., serving as 10% owner at Spyglass Pharma, Inc. (SGP), purchased 937,500 shares at $16.00 per share, for a total transaction value of $15,000,000.00. Following this transaction, New Enterprise Associates 17, L.P. now holds 6,035,038 shares of SGP.
This purchase represents a 18.00% increase in New Enterprise Associates 17, L.P.'s stake in the company. This is considered a high-conviction trade given the significant change in ownership.
The trade was executed on Monday, February 9, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, February 11, 2026, 2 days after the trade was made.
Spyglass Pharma, Inc. operates in the NONE sector, specifically within the NONE industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.
